Literature DB >> 7388326

Bile bacteria in patients with benign bile duct stricture.

F R Jackaman, G R Hilson, L Smith.   

Abstract

In a prospective study of 73 patients undergoing hepatodochojejunostomy for benign bile duct stricture who were covered by antibacterial prophylaxis with gentamicin and cephalolothin, bacteria were cultured from bile sampled at operation in 80 per cent of cases. Aerobic organisms were found in 50 cases (82 per cent) and anaerobic organisms in 11 cases (18 per cent). Seventy-three per cent of the patients with postoperative septic complications had bile cultures positive for anaerobes at operation, and the same organisms were cultured from pus. All patients with anaerobes in the bile at some time in the perioperative period developed postoperative sepsis. Antibacterial prophylaxis with gentamicin and cephalothin, together with specific therapy with drugs effective against anaerobes when indicated, are recommended in the management of these cases.

Entities:  

Mesh:

Year:  1980        PMID: 7388326     DOI: 10.1002/bjs.1800670509

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  10 in total

1.  Expectant management of patients with unilateral hepatic duct stricture and liver atrophy.

Authors:  N S Hadjis; D Carr; I Blenkharn; L Banks; R Gibson; L H Blumgart
Journal:  Gut       Date:  1986-10       Impact factor: 23.059

Review 2.  Antibiotics in the treatment of biliary infection.

Authors:  J S Dooley; J M Hamilton-Miller; W Brumfitt; S Sherlock
Journal:  Gut       Date:  1984-09       Impact factor: 23.059

3.  The effect of cholestasis on hepatic clearance of bacteria.

Authors:  V Cardoso; A Pimenta; J C da Fonseca; J S Rodrigues; M J Vaz
Journal:  World J Surg       Date:  1982-05       Impact factor: 3.352

4.  Obstructive jaundice causes reduced expression of polymorphonuclear leucocyte adhesion molecules and a depressed response to bacterial wall products in vitro.

Authors:  S Plusa; N Webster; J Primrose
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

5.  Characterization of the gut microbiota in patients with primary sclerosing cholangitis compared to inflammatory bowel disease and healthy controls.

Authors:  Samaneh Ostadmohammadi; Masoumeh Azimirad; Hamidreza Houri; Kaveh Naseri; Ehsan Javanmard; Hamed Mirjalali; Abbas Yadegar; Amir Sadeghi; Hamid Asadzadeh Aghdaei; Mohammad Reza Zali
Journal:  Mol Biol Rep       Date:  2021-07-25       Impact factor: 2.316

6.  Bacteriological study of transhepatically aspirated bile. Relation to cholangiographic findings in 295 patients.

Authors:  Y Suzuki; A Kobayashi; M Ohto; Y Tsuchiya; H Saisho; K Kimura; T Ono; K Okuda
Journal:  Dig Dis Sci       Date:  1984-02       Impact factor: 3.199

7.  Impaired bacterial clearance and trapping in obstructive jaundice.

Authors:  S Katz; J L Grosfeld; K Gross; D A Plager; D Ross; R S Rosenthal; M Hull; T R Weber
Journal:  Ann Surg       Date:  1984-01       Impact factor: 12.969

Review 8.  Biliary tract infections: a guide to drug treatment.

Authors:  J F Westphal; J M Brogard
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

9.  Gangrenous cholecystitis and acute cholangitis associated with anaerobic bacteria in bile.

Authors:  C Marne; R Pallarés; R Martín; A Sitges-Serra
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

10.  Experimental bacterial infection of the biliary tract.

Authors:  F R Jackaman; C M Triggs; V Thomas; G R Hilson
Journal:  Br J Exp Pathol       Date:  1980-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.